Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-154

I have never seen so much excitement around a no-licence fee and no-milestone payment research agreement as what we are currently seeing on these threads regarding Medicxi.

I suppose everything else has so far come to nought, including terminated trials, stalled partnerships, a de-prioritised former flagship DEP drug, dumping from the ASX300 then All Ordinaries, no broker coverage, institutions still dumping, cold shoulders from multinational big Pharma, another slap down from the FDA and pitiful sales on commercialised products.

So the desperation is real and apparent: Grab onto any news and claim it’s the best thing since sliced bread. All the while being inspired by the captain of team brown who is egging people on now with predictions of 1000% increase in share price within the next 24 weeks.

Just wow. I’m glad the share price is showing tiny green shoots but jee wiz, cool your jets people.